Solventum Corporation (SOLV) Financial Statements
Historical financial data — 19 statements covering FY2021–FY2025
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since be...
Solventum Corporation's revenue increased 0.9% year over year, from $8.25B to $8.32B.
Net income increased 224.8% over the same period, from $479.0M to $1.56B.
Over the 4-year period from FY2021 to FY2025, revenue grew by 2% in total.
Total debt decreased by 37.1% to $5.04B.
The debt-to-equity ratio stands at 1.00, indicating a moderate leverage profile.
Operating cash flow declined 68.9% to $369.0M.
Solventum Corporation maintains a healthy net profit margin of 18.7%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $2.08B+0.0% | $122.0M | $1.17B | $275.0M | $169.0M | $14.74B | $8.11B | $3.19B |
| Q4 FY2024 | $2.08B-0.3% | $31.0M | $1.12B | $136.0M | $219.0M | $14.46B | $8.01B | $2.96B |
| Q1 FY2025 | $2.07B-0.2% | $137.0M | $1.11B | $152.0M | $29.0M | $14.53B | $7.91B | $3.26B |
| Q2 FY2025 | $2.16B+4.4% | $90.0M | $1.18B | $215.0M | $169.0M | $15.07B | $7.82B | $3.65B |
| Q3 FY2025 | $2.10B-3.0% | $1.27B | $1.14B | $1.69B | $76.0M | $13.97B | $5.14B | $4.99B |
| Q4 FY2025 | $2.00B-4.7% | $63.0M | $1.03B | $-1.38B | $95.0M | $14.29B | $5.04B | $5.05B |
| Q1 FY2026 | $2.01B+0.5% | $13.0M | $1.10B | $81.0M | $-189.0M | N/A | N/A | N/A |
| Q2 FY2026 | $2.21B+10.1% | $92.0M | $1.28B | $181.0M | $227.0M | N/A | N/A | N/A |
Balance Sheet Summary (FY2025)
Solventum Corporation (SOLV) Financial Statements & Revenue History
Solventum Corporation (SOLV) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry trading at $85.81 with a market capitalization of $15. This page provides 19 historical financial statements for Solventum Corporation, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Solventum Corporation reported revenue of $8.3 billion, representing 0.9% year-over-year growth. The net profit margin of 18.7% reflects strong profitability. The debt-to-equity ratio of 1.00 reflects moderate leverage.
SOLV Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Solventum Corporation's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether SOLV is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track SOLV's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Solventum Corporation converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of SOLV's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use SOLV Financial Data
Investors use Solventum Corporation's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare SOLV's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how SOLV's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View SOLV's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Solventum Corporation's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.SOLV trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.